Meetings of the National Biodefense Science Board, 52923-52924 [2013-20793]

Download as PDF Federal Register / Vol. 78, No. 166 / Tuesday, August 27, 2013 / Notices technology/vendors.html, provides a useful roadmap for developers to review. It is a simple, web-based checklist utilized by HHS officials to allow vendors to document how their products do or do not meet the various Section 508 requirements. No HHS, ONC, or other federal government logo—The app must not use HHS’, ONC’s, or any other federal government agency’s logos or official seals in the Submission, and must not claim endorsement. Functionality/Accuracy—A Submission may be disqualified if the software application fails to function as expressed in the description provided by the user, or if the software application provides inaccurate or incomplete information. Security—Submissions must be free of malware. Contestant agrees that ONC may conduct testing on the app to determine whether malware or other security threats may be present. ONC may disqualify the app if, in ONC’s judgment, the app may damage government or others’ equipment or operating environment. tkelley on DSK3SPTVN1PROD with NOTICES Additional Information General Conditions: ONC reserves the right to cancel, suspend, and/or modify the Contest, or any part of it, for any reason, at ONC’s sole discretion. Participation in this Contest constitutes a contestant’s full and unconditional agreement to abide by the Contest’s Official Rules found at www.challenge.gov. Privacy Policy: ChallengePost collects personal information from you when you register on Challenge.gov. The information collected is subject to the ChallengePost privacy policy located at www.challengepost.com/privacy. Ownership of intellectual property is determined by the following: • Each entrant retains title and full ownership in and to their submission. Entrants expressly reserve all intellectual property rights not expressly granted under the challenge agreement. • By participating in the challenge, each entrant hereby irrevocably grants to Sponsor and Administrator a limited, non-exclusive, royalty-free, worldwide license and right to reproduce, publically perform, publically display, and use the Submission to the extent necessary to administer the challenge, and to publically perform and publically display the Submission, including, without limitation, for advertising and promotional purposes relating to the challenge. Authority: 15 U.S.C. 3719. VerDate Mar<15>2010 15:54 Aug 26, 2013 Jkt 229001 Dated: August 19, 2013. David Muntz, Principal Deputy National Coordinator for Health Information Technology. [FR Doc. 2013–20790 Filed 8–26–13; 8:45 am] BILLING CODE 4150–45–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Office of the Assistant Secretary for Health, Office of the Secretary, HHS. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https:// www.hhs.gov/nvpo/nvac, email nvpo@ hhs.gov, or call 202–690–5566 and provide name, organization, and email address. SUMMARY: The meeting will be held on September 10–11, 2013. The meeting times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/ nvpo/nvac as soon they become available. DATES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 690– 4631; email: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters ADDRESSES: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 52923 related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The topics to be discussed at the NVAC meeting will include updates from the NVAC working groups on Human Papillomavirus (HPV) Vaccine and Maternal Immunization, Healthy People 2020 Immunization objectives, immunizations and the Affordable Care Act, deliberation and vote on the NVAC Report on Global Immunization and NVAC Adult Immunization Standards of Practice. The meeting agenda will be posted on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac prior to the meeting. Public attendance at the meeting is limited to space available. Please note agenda meeting times are approximate and are subject to change. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods on the agenda. Individuals who would like to submit written statements should email or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Dated: August 20, 2013. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. 2013–20797 Filed 8–26–13; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings of the National Biodefense Science Board Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the National Biodefense Science Board (NBSB) will be holding a public meeting on September 12, 2013. DATES: The September 12, 2013, NBSB public meeting is tentatively scheduled from 1:00 p.m. to 3:00 p.m. EST, both in-person in Washington, DC and with teleconference connectivity. The agenda SUMMARY: E:\FR\FM\27AUN1.SGM 27AUN1 tkelley on DSK3SPTVN1PROD with NOTICES 52924 Federal Register / Vol. 78, No. 166 / Tuesday, August 27, 2013 / Notices for the September 12, 2013 public meeting is subject to change as priorities dictate. Please check the NBSB Web site at WWW.PHE.GOV/NBSB for the most up-to-date information and for all attendance information. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Pre-registration is required for all members of the public wishing to attend this meeting in-person by September 5, 2013; all attendees must be signed in by a federal staff member. To attend either in-person or by teleconference, please refer to the NBSB Web site for further instructions at WWW.PHE.GOV/NBSB. Please arrive, or call in, 15 minutes prior to the beginning of the meeting to facilitate attendance. Additional Information for Public Participants: These meetings are open to the public and are limited only by the space available. Meeting rooms will accommodate up to 25 people. Preregistration is required for in-person attendance. Individuals who wish to attend the meeting in-person should send an email to NBSB@HHS.GOV with ‘‘NBSB Registration’’ in the subject line by no later than Thursday, September 5, 2013. FOR FURTHER INFORMATION CONTACT: The National Biodefense Science Board mailbox: NBSB@HHS.GOV. SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public Health Service Act (42 U.S.C. 247d–7f ) and section 222 of the Public Health Service Act (42 U.S.C. 217a), the Department of Health and Human Services (HHS) established the National Biodefense Science Board. The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to HHS regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. The Board may also provide advice and guidance to the Secretary and/or the Assistant Secretary for Preparedness and Response (ASPR) on other matters related to public health emergency preparedness and response. Background: Part of the September 12, 2013, public meeting will be dedicated to the NBSB’s deliberation and vote on the findings from the Situational Awareness Working Group; the remainder of the meeting will be dedicated to presentation of a potential new task to the NBSB, and an overview of NBSB accomplishments presented by the NBSB Chair, Dr. John Parker. Subsequent agenda topics will be added as priorities dictate. Any additional VerDate Mar<15>2010 15:54 Aug 26, 2013 Jkt 229001 agenda topics will be available on the NBSB’s September 2013 meeting Web page prior to the public meeting, available at WWW.PHE.GOV/NBSB. Availability of Materials: The meeting agenda and materials will be posted on the NBSB Web site at WWW.PHE.GOV/ NBSB prior to the meeting. Procedures for Providing Public Input: All members of the public are encouraged to provide written comment to the NBSB. All written comments must be received prior to September 9, 2013, and should be sent by email to NBSB@HHS.GOV with ‘‘NBSB Public Comment’’ as the subject line. Individuals planning to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should email NBSB@ HHS.GOV. Dated: August 20, 2013. Nicole Lurie, Assistant Secretary for Preparedness and Response. [FR Doc. 2013–20793 Filed 8–26–13; 8:45 am] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Office of the Assistant Secretary for Health, Statement of Organization, Functions, and Delegations of Authority Part A, Office of the Secretary, Statement of Organization, Function, and Delegation of Authority for the U.S. Department of Health and Human Services (HHS) is being amended at Chapter AC, Office of the Assistant Secretary for Health (OASH), as last amended at 77 FR 60996–97, dated October 5, 2012, and 72 FR 58095–96, dated October 12, 2002. The amendment reflects the realignment of personnel oversight, administration and management functions for the Office on Women’s Health (OWH) in the OASH. Specifically, this notice establishes the Division of Policy and Performance Management (ACB2), the Division of Strategic Communication (ACB3) and the Division of Program Innovation (ACB4) within the Office on Women’s Health (ACB). The changes are as follows: I. Under Part A, Chapter AC, Office of the Assistant Secretary for Health, make the following changes: A. Under Section AC.20, Functions, ‘‘B. Office on Women’s Health (ACB), Section 1. Immediate Office of the Director (ACB1)’’ replace the entire section with: PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 1. Immediate Office of the Director (ACB1). The Immediate Office of the Director, headed by the Deputy Director of the Office on Women’s Health, is responsible for operations and administrative management, HR management, and budget planning and coordination. The office coordinates the programmatic aspects of HHS components in regards to issues relating to women’s health; serves as the locus within HHS to identify changing needs, to recommend new studies, and to assess new challenges to the health of women; serves as a focal point within HHS to coordinate the continuing implementation of health objectives for the future; assures liaison occurs with relevant HHS agencies and offices; and facilitates the expansion of services and access to health care for all women. The Deputy Director plans and directs financial management activities, including budget formulation and execution; provides liaison on personnel management activities with the OASH and the Program Support Center; and is responsible for implementing the congressional, international health and national (regional) components for the OWH mission. The office also provides scientific analyses for all initiatives. B. Under Section AC.20, Functions, ‘‘B. Office on Women’s Health (ACB), Section 2. Division of Program Coordination (ACB2)’’ replace the entire section with: 2. Division of Policy and Performance Management (ACB2). The Division of Policy and Performance Management, headed by the Division Director, is responsible for strategic planning; policy review, development and analysis; and program evaluation and performance management. The division forecasts future OWH direction, leads strategic and operational plans development; supports and monitors their implementation; leads the design, management, and monitoring of evidence based women’s health programs for targeted issues; advises director on policy issues and engages stakeholders, organizations, and partners in reviewing, developing and analyzing practices to inform policy development; and leads efforts to incorporate gender specific issues into broader health policy as well as evaluate how those issues are incorporated into health policy. C. Under Section AC.20, Functions, ‘‘B. Office on Women’s Health (ACB), Section 3. Division of Outreach and Collaboration (ACB3)’’ replace the entire section with: 3. Division of Strategic Communication (ACB3). The Division of E:\FR\FM\27AUN1.SGM 27AUN1

Agencies

[Federal Register Volume 78, Number 166 (Tuesday, August 27, 2013)]
[Notices]
[Pages 52923-52924]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-20793]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meetings of the National Biodefense Science Board

AGENCY: Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the National Biodefense Science Board (NBSB) will be holding a public 
meeting on September 12, 2013.

DATES: The September 12, 2013, NBSB public meeting is tentatively 
scheduled from 1:00 p.m. to 3:00 p.m. EST, both in-person in 
Washington, DC and with teleconference connectivity. The agenda

[[Page 52924]]

for the September 12, 2013 public meeting is subject to change as 
priorities dictate. Please check the NBSB Web site at WWW.PHE.GOV/NBSB 
for the most up-to-date information and for all attendance information.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. 
Pre-registration is required for all members of the public wishing to 
attend this meeting in-person by September 5, 2013; all attendees must 
be signed in by a federal staff member. To attend either in-person or 
by teleconference, please refer to the NBSB Web site for further 
instructions at WWW.PHE.GOV/NBSB. Please arrive, or call in, 15 minutes 
prior to the beginning of the meeting to facilitate attendance.
    Additional Information for Public Participants: These meetings are 
open to the public and are limited only by the space available. Meeting 
rooms will accommodate up to 25 people. Pre-registration is required 
for in-person attendance. Individuals who wish to attend the meeting 
in-person should send an email to NBSB@HHS.GOV with ``NBSB 
Registration'' in the subject line by no later than Thursday, September 
5, 2013.

FOR FURTHER INFORMATION CONTACT: The National Biodefense Science Board 
mailbox: NBSB@HHS.GOV.

SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public 
Health Service Act (42 U.S.C. 247d-7f ) and section 222 of the Public 
Health Service Act (42 U.S.C. 217a), the Department of Health and Human 
Services (HHS) established the National Biodefense Science Board. The 
Board shall provide expert advice and guidance to the Secretary on 
scientific, technical, and other matters of special interest to HHS 
regarding current and future chemical, biological, nuclear, and 
radiological agents, whether naturally occurring, accidental, or 
deliberate. The Board may also provide advice and guidance to the 
Secretary and/or the Assistant Secretary for Preparedness and Response 
(ASPR) on other matters related to public health emergency preparedness 
and response.
    Background: Part of the September 12, 2013, public meeting will be 
dedicated to the NBSB's deliberation and vote on the findings from the 
Situational Awareness Working Group; the remainder of the meeting will 
be dedicated to presentation of a potential new task to the NBSB, and 
an overview of NBSB accomplishments presented by the NBSB Chair, Dr. 
John Parker. Subsequent agenda topics will be added as priorities 
dictate. Any additional agenda topics will be available on the NBSB's 
September 2013 meeting Web page prior to the public meeting, available 
at WWW.PHE.GOV/NBSB.
    Availability of Materials: The meeting agenda and materials will be 
posted on the NBSB Web site at WWW.PHE.GOV/NBSB prior to the meeting.
    Procedures for Providing Public Input: All members of the public 
are encouraged to provide written comment to the NBSB. All written 
comments must be received prior to September 9, 2013, and should be 
sent by email to NBSB@HHS.GOV with ``NBSB Public Comment'' as the 
subject line. Individuals planning to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should email NBSB@HHS.GOV.

    Dated: August 20, 2013.
Nicole Lurie,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2013-20793 Filed 8-26-13; 8:45 am]
BILLING CODE 4150-37-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.